Kerendia (Finerenone Tablets): Side Effects, Uses, Dosage ... - RxList
https://www.rxlist.com/kerendia-drug.htm
WebSep 15, 2022 · Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist ( MRA) indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal heart attack ( myocardial infarction ), and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) …
DA: 39 PA: 74 MOZ Rank: 38 Up or Down: Up